Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...